3
Announcements
Trials
Browse
Landscape
Status
No longer available
4
Unknown
1
Approved for marketing
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Conditions
Myasthenic Syndromes, Congenital
1
Lambert-Eaton Myasthenic Syndrome
1
Interventions
gallium 68 PSMA-11
2
Oxaliplatin
2
Magnetic Resonance Spectroscopy
2
Fluorouracil
2
motexafin gadolinium
1
glucarpidase
1
Positron-Emission Tomography
1
Leucovorin
1
Laparoscopy
1
Gemtuzumab
1
Gadolinium
1
Carboxypeptidases
1
Amifampridine
1
3-Iodobenzylguanidine
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Approved for marketing
×
OTHER
×
Amifampridine
×
Clear all
NCT00872950
2022-04-11
LEMS
Lahey Clinic
Approved for marketing